{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:36:30Z","timestamp":1771230990281,"version":"3.50.1"},"reference-count":57,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Complementary and alternative medicines (CAMs) are frequently discussed by people with Inflammatory Bowel Disease (IBD). The aim of this study is to explore CAM use in Australians with IBD. This cross-sectional study was conducted via an anonymous online survey, predominantly distributed through IBD-specific social media accounts. Data collection occurred over a three-month period in 2021. Descriptive statistics, Chi-Square tests, and binary logistic regression were used to analyse quantitative data. A simple thematic analysis was conducted for qualitative free-text responses. Of the 123 responses, acupuncture (12.2%) and chiropractors (8.9%) were common CAM practitioners accessed. CAM practitioners were perceived to be \u2018very helpful\u2019 compared to mainstream health practitioners. The most common CAM products reported were vitamins (51.2%), probiotics (43.9%), and herbal medicine (30.9%). Common reasons for use were improved perceived improvements to wellbeing or for long-term management of IBD. Females were more likely to access CAM practitioners (OR 12.6, 95% CI 1.62\u201398.1, p = 0.02). Doctors were the participants\u2019 primary source of information (64.2%), although many expressed dissatisfaction with conventional therapy and the desire for a more holistic approach to care. The use of CAMs in this sample was high. Limited research into the efficacy and safety of these therapies may prevent health professionals from discussing their use with patients. Improved communication with health professionals will allow patients to be active partners in their healthcare plans and can heighten patient satisfaction with conventional therapy.<\/jats:p>","DOI":"10.3390\/ijerph21091140","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:52:08Z","timestamp":1724831528000},"page":"1140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"21","author":[{"given":"Laura","family":"Frank","sequence":"first","affiliation":[{"name":"School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, NSW 2522, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-7328","authenticated-orcid":false,"given":"Kelly","family":"Lambert","sequence":"additional","affiliation":[{"name":"School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, NSW 2522, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e042493","DOI":"10.1136\/bmjopen-2020-042493","article-title":"Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study","volume":"11","author":"Williams","year":"2021","journal-title":"BMJ Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ecco-jcc\/jjz051","article-title":"European Crohn\u2019s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease","volume":"13","author":"Torres","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ibd\/izy276","article-title":"Quality of Care in Patients With Inflammatory Bowel Disease","volume":"25","author":"Jackson","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40271-019-00407-5","article-title":"A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective","volume":"13","author":"Louis","year":"2020","journal-title":"Patient\u2014Patient-Centered Outcomes Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11938-019-00222-9","article-title":"Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease","volume":"17","author":"Ma","year":"2019","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jcag\/gwy060","article-title":"Integrated Care Models: Optimizing Adult Ambulatory Care in Inflammatory Bowel Disease","volume":"3","author":"Schoenfeld","year":"2020","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jgh3.12236","article-title":"Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes","volume":"4","author":"Massuger","year":"2020","journal-title":"JGH Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ibd\/izy327","article-title":"A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD","volume":"25","author":"Christian","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mayocp.2017.04.010","article-title":"Crohn Disease: Epidemiology, Diagnosis, and Management","volume":"92","author":"Cheifetz","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5217\/ir.2018.00033","article-title":"Medication non-adherence in inflammatory bowel diseases is associated with disability","volume":"16","author":"Perry","year":"2018","journal-title":"Intest. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jgh3.12537","article-title":"Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic","volume":"5","author":"Barnes","year":"2021","journal-title":"JGH Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: Clinical aspects and treatments","volume":"7","author":"Fakhoury","year":"2014","journal-title":"J. Inflamm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/codi.15301","article-title":"A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis","volume":"23","author":"Baker","year":"2021","journal-title":"Color. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"i445","DOI":"10.1093\/ecco-jcc\/jjab232.602","article-title":"P475 Profiling the use of Complementary Alternative Medicines among IBD patients","volume":"16","author":"Sudhakar","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ibd.21094","article-title":"A new tool to measure the burden of Crohn\u2019s disease and its treatment","volume":"16","author":"Wilcox","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","unstructured":"(2022, April 01). National Library of Medicine, Complementary Therapies, Available online: https:\/\/www.ncbi.nlm.nih.gov\/mesh\/68000529."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ibd.21360","article-title":"Use of Complementary and Alternative Medicine by Patients with Inflammatory Bowel Disease","volume":"17","author":"Hilsden","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1756284820927550","DOI":"10.1177\/1756284820927550","article-title":"Complementary and alternative medications in the management of inflammatory bowel disease","volume":"13","author":"Picardo","year":"2020","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lindberg, A., Ebbeskog, B., Karlen, P., and Oxelmark, L. (2013). Inflammatory bowel disease professionals\u2019 attitudes to and experiences of complementary and alternative medicine. BMC Complement. Altern. Med., 13.","DOI":"10.1186\/1472-6882-13-349"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctim.2004.09.006","article-title":"Disclosure of CAM use to medical practitioners: A review of qualitative and quantitative studies","volume":"23","author":"Robinson","year":"2004","journal-title":"Complement. Ther. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lindberg, A., Fossum, B., Karlen, P., and Oxelmark, L. (2014). Experiences of complementary and alternative medicine in patients with inflammatory bowel disease\u2014A qualitative study. BMC Complement. Altern. Med., 14.","DOI":"10.1186\/1472-6882-14-407"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3748\/wjg.v21.i12.3663","article-title":"Doctor communication quality and Friends\u2019 attitudes in uence complementary medicine use in in ammatory bowel disease","volume":"21","author":"Mountifield","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17512433.2021.1925108","article-title":"Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD)","volume":"14","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MIB.0b013e31827f27c8","article-title":"Use and Predictors of Oral Complementary and Alternative Medicine by Patients With Inflammatory Bowel Disease: A Population-Based, Case\u2013Control Study","volume":"19","author":"Koning","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ctim.2013.12.001","article-title":"Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea","volume":"22","author":"Park","year":"2014","journal-title":"Complement. Ther. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.crohns.2009.11.011","article-title":"Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease","volume":"4","author":"Lakatos","year":"2010","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.dld.2016.12.031","article-title":"The who-when-why triangle of complementary and alternative medicine use among Portuguese IBD patients","volume":"49","author":"Portela","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J. Med. Internet Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/acm.2008.0521","article-title":"Development of an International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q)","volume":"15","author":"Quandt","year":"2009","journal-title":"J. Altern. Complement. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1155\/2012\/735386","article-title":"The information needs and preferences of persons with longstanding inflammatory bowel disease","volume":"26","author":"Wong","year":"2012","journal-title":"Can. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and Prevalence of Crohn\u2019s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11606-008-0520-5","article-title":"Validation of screening questions for limited health literacy in a large VA outpatient population","volume":"23","author":"Chew","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jhn.13297","article-title":"What do people with inflammatory bowel disease want to know about diet? The dietary information needs of people with inflammatory bowel disease and perceptions of healthcare providers","volume":"37","author":"Miglioretto","year":"2024","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/1747-0080.12843","article-title":"A scoping review of the dietary information needs of people with inflammatory bowel disease","volume":"81","author":"Miglioretto","year":"2024","journal-title":"Nutr. Diet."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Akutko, K., and Stawarski, A. (2021). Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112466"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/apt.14203","article-title":"Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease","volume":"46","author":"Derwa","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Jakubczyk, D., Leszczy\u0144ska, K., and G\u00f3rska, S. (2020). The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review. Nutrients, 12.","DOI":"10.3390\/nu12071973"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11821","DOI":"10.21037\/apm-21-2996","article-title":"Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1521-6918(03)00076-3","article-title":"Probiotics in inflammatory bowel disease: A critical review","volume":"17","author":"Tamboli","year":"2003","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2146\/ajhp090168","article-title":"Probiotics","volume":"67","author":"Williams","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/00365521.2022.2078667","article-title":"Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): Results from a German nationwide survey of 2019 compared to a previous survey of 2002","volume":"57","author":"Bauer","year":"2022","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Day, A.S. (2013). A review of the use of complementary and alternative medicines by children with inflammatory bowel disease. Front. Pediatr., 1.","DOI":"10.3389\/fped.2013.00009"},{"key":"ref_43","first-page":"415","article-title":"The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease","volume":"14","author":"Lin","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"otaa015","DOI":"10.1093\/crocol\/otaa015","article-title":"Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients","volume":"2","author":"Benson","year":"2020","journal-title":"Crohns Colitis 360"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1097\/01.MIB.0000435851.94391.37","article-title":"Marijuana use patterns among patients with inflammatory bowel disease","volume":"19","author":"Courtwright","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ibd\/izy319","article-title":"The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information","volume":"25","author":"Swaminath","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_47","first-page":"668","article-title":"Therapeutic Use of Cannabis in Inflammatory Bowel Disease","volume":"12","author":"Ahmed","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MIB.0000000000000585","article-title":"Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease","volume":"22","author":"Limdi","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Guida, L., Di Giorgio, F.M., Busacca, A., Carrozza, L., Ciminnisi, S., Almasio, P.L., Di Marco, V., and Cappello, M. (2021). Perception of the Role of Food and Dietary Modifications in Patients with Inflammatory Bowel Disease: Impact on Lifestyle. Nutrients, 13.","DOI":"10.3390\/nu13030759"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/apt.16549","article-title":"Systematic review with meta-analysis: Dietary intake in adults with inflammatory bowel disease","volume":"54","author":"Lambert","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0148607114549254","article-title":"What Are Adults With Inflammatory Bowel Disease (IBD) Eating? A Closer Look at the Dietary Habits of a Population-Based Canadian IBD Cohort","volume":"40","author":"Vagianos","year":"2016","journal-title":"JPEN J. Parenter. Enteral. Nutr"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clnu.2019.11.002","article-title":"ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2036.2010.04386.x","article-title":"Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet","volume":"32","author":"Wild","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/2050640619841249","article-title":"Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease","volume":"7","author":"Schreiner","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ctim.2010.05.034","article-title":"Barriers to patient referral for Complementary and Alternative Medicines and its implications on interventions","volume":"18","author":"Wong","year":"2010","journal-title":"Complement. Ther. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/acm.2006.12.281","article-title":"Variation in complementary and alternative medicine (CAM) use across racial\/ethnic groups and the development of ethnic-specific measures of CAM use","volume":"12","author":"Hsiao","year":"2006","journal-title":"J. Altern. Complement. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lungaro, L., Costanzini, A., Manza, F., Barbalinardo, M., Gentili, D., Guarino, M., Caputo, F., Zoli, G., De Giorgio, R., and Caio, G. (2023). Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review. J. Pers. Med., 13.","DOI":"10.3390\/jpm13020165"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/21\/9\/1140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:44:20Z","timestamp":1760111060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/21\/9\/1140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijerph21091140"],"URL":"https:\/\/doi.org\/10.3390\/ijerph21091140","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]}}}